BuyRetaUK buyRetaUK sells GLP-1 compounds (retatrutide, tirzepatide, semaglutide) and says 'every batch is independently tested by third-party labs via HPLC and mass spectrometry,' but names no laboratory and offers no certificate you can verify. The domain was registered on 16 June 2026, only weeks ago, and the trading company, Oxford Research Syndicate Ltd (Companies House 17207898), gives a Barking, Essex address that has nothing to do with the 'Oxford' branding. A brand-new shop moving patented GLP-1 medicines behind an unverifiable testing claim warrants real caution.
The Peptide Watch benchmarks every vendor on the same compound, BPC-157, the most common research peptide, as £ per milligram, so prices are directly comparable across all providers. No public BPC-157 price feed was available for this vendor at audit.
| Check | Result |
|---|---|
| Verifiable certificate in its own name | No |
| Independent lab named | None named / unverifiable |
| Tests its own stock | No evidence |